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Abstract 
Binding of protoporphyrin caused a perturbation of the erythrocyte membrane, as reflected by a change in cell shape from discoid to 
echinocyte, and a concomitant increase in mean cellular volume and K+-loss. Protoporphyrin-induced hanges could be prevented by the 
presence of BaC12, whereas binding of protoporphyrin was not affected. Exposure of erythrocytes to hydrogen peroxide leads to 
K+-leakage and lipid peroxidation. In de presence of protoporphyrin, HzO2-induced K+-leakage was enhanced, whereas lipid 
peroxidation was inhibited. The increase in H202-induced K+-leakage by protoporphyrin was not affected by diamide or various K + 
channel blockers, but cou]Ld be prevented by the addition of BaCI 2. The inhibition of lipid peroxidation, on the other hand, was not 
affected by BaC12- These results indicate that the enhancement of H 202-induced K+-leakage was most likely caused by the change in cell 
shape. Addition of chloq~romazine and promethazine, positively charged molecules that induce stomatocytosis, did not cause an 
enhancement of H 202-indaced K+-leakage. 
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1. Introduction 
Oxidative stress is thought o play an important role in 
many physiological and pathological phenomena. Erythro- 
cytes have been used extensively as a model to investigate 
oxidative damage, with special emphasis on membrane 
damage [1-5]. An important consideration i this context 
is the absence of DNA and subcellular structures in human 
red blood cells, excluding several mechanisms of cell 
injury. On the other hand, the presence of hemoglobin 
often plays an important role in various reactions. Erythro- 
cyte membrane damage, can be reflected, e.g., by leakage 
of cellular constituents, uch as K +, to the medium and 
lipid peroxidation. It has been found that erythrocytes are 
more susceptible to oxidative stress in disorders with 
intrinsic membrane defects, such as sickle cell anemia 
[6,7]. This increased susceptibility of sickle cells has been 
Abbreviations: TBARS, thiobarbitufic acid reactive substances; TBA, 
thiobarbituric acid; PBS, phosphate-buffered saline; MCV, mean cellular 
volume; BHT, butylated hydroxytoluene. 
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attributed to the instability of sickle hemoglobin and to 
impaired protective mechanisms, but also to the loss of 
membrane structural integrity that accompanies the change 
in cell shape. 
We found that exposure of erythrocytes to protopor- 
phyrin resulted in a change in cell shape, which is de- 
scribed in this paper. Porphyrin accumulation occurs in a 
group of diseases called the porphyrias. The porphyrias are 
caused by various enzyme deficiencies in the heine synthe- 
sis [8]. In erythropoietic protoporphyria the enzyme fer- 
rochelatase, which catalyses the insertion of ferrous iron 
into protoporphyrin, is affected and protoporphyrin accu- 
mulates in liver and erythroid cells [8,9]. The major clini- 
cal manifestation of this disease is a pronounced hyper- 
sensitivity of the skin to visible light, caused by the 
sensitizing properties of protoporphyrin accumulated in the 
skin. Furthermore, it has been found that liver disease 
occurs more frequently than normal in patients with ery- 
thropoietic protoporphyria, most likely due to massive 
accumulation of protoporphyrin  liver tissue [8]. Hemoly- 
sis has only occasionally been reported in erythropoietic 
protoporphyria, usually in association with liver disease 
and it has been suggested that there might be a causal 
relationship between liver disease and hemolysis [10]. 
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Since the susceptibility of cells to oxidative damage 
depends on the integrity of the membrane structure, it is 
possible that protoporphyrin, by changing the shape of the 
cell, also affects its susceptibility to oxidative stress. Ox- 
idative damage as a result of exposure to light in the 
presence of porphyrins, has been studied extensively [11- 
13]. However, not much is known about the effects of 
protoporphyrin on erythrocytes in the dark. In the present 
paper we have investigated the susceptibility of erythro- 
cytes towards hydrogen peroxide in the presence of proto- 
porphyrin and it is shown that the susceptibility of the cells 
is indeed changed by the presence of protoporphyrin. 
2. Materials and methods 
Protoporphyrin IX and uroporphyrin III were purchased 
from Porphyrin Products (Logan, UT). Bilirubin IX was 
obtained from ICN Biochemicals (Zoetermeer, The Nether- 
lands). J4C-labelled inulin came from Amersham, UK. All 
other reagents were of analytical grade and used without 
further purification• All solutions were prepared in water 
that had been passed through a Millipore Milli-Q ultrapu- 
rification system and were made up freshly before use. 
Stock solutions (1 mM) of porphyrins and bilirubin were 
made in 4 mM NaOH. To avoid photoexcitation of the 
porphyrins and bilirubin the incubation mixtures were 
prepared and handled under dim light. 
Heparinized human blood was centrifuged shortly after 
collection• The erythrocytes were washed three times and 
resuspended at 10% hematocrit n PBS. Erythrocytes were 
exposed to H202 (20 mM) at 30°C in the presence of 2 
mM sodium azide, to inhibit endogenous catalase activity. 
In some experiments erythrocytes were washed twice with 
PBS and once with 10 mM Tris-HC1 pH 7.4, containing 
100 mM BaC12. Subsequently, the erythrocytes were re- 
suspended at 10% hematocrit n 10 mM Tris-HC1 pH 7.4, 
containing 100 mM BaC12. Preincubation of erythrocytes 
with 0.1 mM bumetanide was performed at 30°C for 30 
rain as described by Johnson and Tang [14]. Cells were 
preincubated with 1 mM furosemide for 10 min at 30°C 
and with 0.1 mM ouabain for 5 rain at room temperature 
[15]. 
Hemoglobin-free ghosts were prepared by the gradual 
osmotic lysis method of Weed et al. [16]. Protein was 
determined as described by Lowry et al. using albumin as 
a standard [ 17]. 
Binding of porphyrins to erythrocytes was determined 
by extraction of protoporphyrin into ethyl acetate and 
subsequently into HC1. The latter step is necessary to 
remove heme, which interferes with the fluorescence mea- 
surements. A 10% erythrocyte suspension was incubated 
with protoporphyrin (final concentrations: 0-50 ~M) at 
30 ° C. After incubation (0-30 min) the cells were washed 
twice with PBS and resuspended at 1% hematocrit n PBS. 
1 ml of this suspension was extracted with 4 ml acetic 
acid/ethyl acetate (1:4). To 1 ml of the ethyl acetate layer 
3 ml of 3 M HCI were added. After centrifugation the 
fluorescence of the HC1 layer was determined (excitation 
405 rim; emission 632 nm). By this method 90% of the 
added protoporphyrin could be recovered. Fluorescence 
data were obtained using an Aminco SPF 500 spectro- 
fluorometer. 
K+-leakage from red blood cells was determined with a 
flame photometer (Clinical Flame Photometer 410 c, Com- 
ing) and expressed as percentage of total effiux evoked by 
lysis of the cells in distilled water. The mean cellular 
volume was measured by centrifuging 0.3 ml of a 10% 
erythrocyte suspension during 20 min at 3000 rpm in a 
Hamburger-type hematocrit ube, correcting the packed 
cell volume for trapped medium. Trapped medium be- 
tween packed cells was determined by adding 2% ~4C- 
labelled inulin to the medium, prior to centrifugation. 0 05 
ml of packed cells was resuspended in 2 ml PBS and the 
radioactivity of the supernatant of this suspension was 
measured by scintillation counting• Cell morphology was 
assessed by light microscopy of cell suspensions after 
fixation of the cells in PBS + 2% glutaraldehyde for 1 h. 
Lipid peroxidation was assayed by measuring the gener- 
ation of TBARS [18,19]• Briefly, reactions were stopped 
by addition of 0.75 ml of 28% (w/v)  trichloroacetic acid 
and 1.3% (w/v)  of sodium arsenite to 1.5 ml samples. 
After centrifugation, 1.5 ml of the supernatant were added 
to 0.75 ml of 1% TBA in 0.05 M NaOH containing 0.1 
mM BHT. Subsequently, samples were heated at 100°C 
for 15 min, and after cooling the absorption at 532 nm was 
measured (extinction coefficient for malondialdehyde, 1.56 
• 105 M 1 cm ~). Absorption measurements were carried 
out using a Beckman DU 64 spectrophotometer. 
For all experiments, variability did not exceed 10%, 
with three independent experiments for each data point. 
3. Results 
3.1. Effect o f  protoporphyr in  on erythrocytes 
Incubation of erythrocytes with protoporphyrin (10-50 
/~M) at 30 ° C resulted in rapid binding of protoporphyrin 
to the erythrocytes (Fig. 1). Binding amounted to 90% of 
the protoporphyrin added to the incubation mixture. Uro- 
porphyrin, a more hydrophilic porphyrin, did not bind to 
the erythrocytes at all (results not shown). Addition of 
protoporphyrin to the erythrocytes resulted in K+-leakage 
and in an increase in cellular volume (Table 1). The 
amount of K + released from the cells enhanced with 
increasing protoporphyrin concentrations and reached a 
maximum after incubation for 30 min. Protoporphyrin-in- 
duced increase in MCV and K+-leakage was not affected 
by the addition of EGTA, ouabain, furosemide or 
bumetanide or by substituting sucrose for NaC1 (results not 
shown). Replacement of PBS by 10 mM Tris-HCl pH 7.4, 
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Fig. 1. Binding of protopoq~hyrin to erythrocytes. Erythrocytes were 
incubated for 0-30 min with protoporphyrin at 30 ° C. Subsequently 
protoporphyrin was extracted .as described in Materials and methods. (0 )  
l0 txM protoporphyrin; (• )  '.),5 lxM protoporphyrin; (• )  50 /xM proto- 
porphyrin. 
cell membranes the absorbance increased, but there was no 
change in the absorption maximum, showing that the 
localisation of protoporphyrin /at the membrane was 
completely different in the presence of BaC12. 
We compared the effect of protoporphyrin o MCV and 
K+-leakage with the effect of several other compounds, 
amongst them some well-known radical scavengers (Table 
2). Erythrocytes were incubated with these compounds for 
30 min at 30°C and the effect on cell volume and K +- 
leakage was determined. Of these compounds both chlor- 
promazine and promethazine caused an increase in MCV 
and K+-leakage during the preincubation period (Table 2). 
No K÷-leakage or increase in MCV could be observed 
when ceils were incubated with uroporphyrin, bilirubin, 
BHT or diphenylamine. 
3.2. Effect of protoporphyrin on H 2 02-induced K +-leakage 
and lipid peroxidation 
containing 100 mM BaCI 2, prevented protoporphyrin-in- 
duced cell swelling and K+-leakage (Table 1). However, 
binding of protoporphyrin to the erythrocytes was not 
affected under these conditions and again approx. 90% of 
the porphyrin molecule,,; was bound to the cells (Table 1). 
Incubation of erythrocytes with protoporphyrin also re- 
sulted in morphological changes. In PBS the discoid cells 
became chinocytic after exposure to protoporphyrin (Fig. 
2A). Incubation with uroporphyrin did not induce changes 
in cell shape. When these experiments were repeated in 10 
mM Tris-HCl pH 7.4, containing 100 mM BaCI 2, the 
shape of the erythrocytes did not change upon incubation 
with protoporphyrin, but remained iscoid (Fig. 2B). 
The localisation of protoporphyrin i  the red cell mem- 
brane was further studied in ghosts (Fig. 3). The absorp- 
tion spectrum of protoporphyrin i  PBS is typical of 
aggregated species: the absorbance maximum is blue- 
shifted (Area x= 360 nm), broadened and the absorbance is 
low [20]. In the presence of red cell membranes the 
absorbance maximum shifted to 412 nm, which is charac- 
teristic for the mononteric form of the porphyrin. This 
indicates that protoporphyrin molecules were localised in 
the membrane. In Tris-buffered BaCI 2 the absorbance 
maximum of protoporphyrin was slightly shifted to 377 
nm, but still broad and low (Fig. 3). In the presence of red 
In further experiments erythrocytes were always incu- 
bated with protoporphyrin for 30 min at 30 ° C prior to the 
addition of H202. Removal of unbound protoporphyrin 
before the addition of H202 did not influence the results, 
indicating that the observed effects were only due to 
membrane-bound protoporphyrin. H202 was therefore 
added directly after incubation with the porphyrins, with- 
out removing unbound porphyrin molecules. Incubation of 
erythrocytes with H202 resulted in lipid peroxidation and 
K+-leakage, as has been shown previously [1-3]. In the 
presence of protoporphyrin, peroxide-induced lipid per- 
oxidation was inhibited concentration-dependently (Fig. 4). 
The effect of protoporphyrin on peroxide-induced K +- 
leakage, on the other hand, was quite different. Exposure 
of the cells to 20 mM H202 for 15 min resulted in a 
K+-leakage of approx. 20%. Incubation with increasing 
concentrations of protoporphyrin resulted in enhancement 
of the peroxide-induced K+-leakage (Fig. 4). The data 
shown in Fig. 4 are corrected for K+-leakage induced by 
protoporphyrin alone. 
The fate of the protoporphyrin molecules during these 
reactions was also determined. Erythrocytes were exposed 
to H202 in the presence of 50 /~M protoporphyrin. After 
incubation for 120 min, protoporphyrin was extracted from 
the incubation mixture and the fluorescence of the HC1 
Table 1 
Interaction between protoporghyrin and erythrocytes 
Porphyrin PB S Tris/BaC12 
concentration binSing MCV %K+-loss binding MCV %K---loss 
10 ~M 7.8 (91%) 114 10 7.5 (88%) 100 2 
25/~M 18.2 (85%) 115 12 19.1 (89%) 102 2 
50/xM 38.2 (89%) 115 20 38.5 (90%) 102 4 
A 10% erythrocyte suspensien was incubated with protoporphyrin (10-50 p,M) for 30 min at 30 ° C in PBS or in 10 mM Tris-HCl pH 7.4, containing 100 
mM BaCI 2. Binding, MCV and K+-Ieakage were determined as described in Materials and methods. Numbers in parentheses give percentage of total 
amount of protoporphyrin. MCV is expressed as percent of initial value. Initial MCV is 100% and initial K+-Ieakage is 2%. Binding is expressed as 106 
molecules/cell 
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layer was determined. This was compared with the fluores- 
cence of protoporphyrin extracted from an erythrocyte 
suspension ot exposed to H20 2. In both cases no effect 
on the fluorescence of protoporphyrin could be observed, 
indicating that protoporphyrin was not degraded during 
incubation of the erythrocytes with H20 2 (data not shown). 
Fig. 2. Protoporphyrin-induced changes in cell shape. Light micrographs of erythrocytes (10% suspension) exposed to 20 /zM protoporphyrin in PBS (A) 
or in Tris-HCI/BaCI 2 (B). Enlargement: 40X. 
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Fig. 3. Changes in the absorption spectrum of protoporphyrin. Visible 
absorption spectra of 25 /xM protoporphyrin i  PBS (-); or in PBS with 
ghosts (0.2 mg/ml protein) ( -  - -); or in 10 mM Tris-HC1 pH 7.4, 
containing 100 mM BaCI 2 ( . . . .  ); or in 10 mM Tris-HCl pH 7.4, 
containing 100 mM BaCI 2 with ghosts (0.2 mg/ml protein) (.  •, ). When 
necessary the spectra were conected for the absorption of ghosts. 
Protoporphyrin affected both peroxide-induced lipid 
peroxidation and K+-los,;. In further experiments we com- 
pared the effect of protoporphyrin with the effect of vari- 
ous radical scavengers, i.e., bilirubin, BHT, chlorproma- 
zine, promethazine and diphenylamine, on these parame- 
ters. After incubation with these compounds for 30 rain, 
H202 was added and the effect of these compounds on 
peroxide-induced K+-leakage and lipid peroxidation was 
determined (Table 2). Peroxide-induced lipid peroxidation 
was inhibited by all compounds and the rate of inhibition 
was dependent on the compound used. The presence of 
diphenylamine r sulted in a substantial increase in K +- 
leakage, whereas bilirubin, BHT, chiorpromazine and 
promethazine inhibited peroxide-induced K+-leakage 
slightly (Table 2). Uroporphyrin did not affect lipid per- 
oxidation or K+-leakage. 
3.3. The mechanism of the enhancement of peroxide-in- 
duced K +-leakage by protoporphyrin 
In an attempt to further elucidate the effect of protopor- 
phyrin on H202-induced K+-loss and lipid peroxidation, 
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Fig, 4. The effect of protoporphyrin o  H202-induced lipid peroxidation 
and K+-leakage. Erythrocytes were preincubated for 30 min with proto- 
porphyrin (0-100 ~M) and subsequently exposed to 20 mM H202 in the 
presence of 2 mM azide at 30 ° C. After 15 min of incubation in the 
presence of H202, K÷-leakage (0 )  was determined as described in 
'Material and methods'. Lipid peroxidation (O) is expressed as percent- 
age of the amount of TBARS formed by 7.108 cells in 120 rain without 
protoporphyrin present. This amounted to 18.4 nmol TBARS. 
we investigated the effect of BHT and diamide on both 
processes in the presence of I-I202 and protoporphyrin. 
Previous investigations showed that H202-induced lipid 
peroxidation can be inhibited (e.g., by BHT) without af- 
fecting the increased passive cation permeability of the 
membrane. Subsequently we showed, using the SH-reagent 
diamide, that peroxide-induced K+-leakage was most likely 
caused by oxidation of SH-groups in the membrane, a
process that was independent of lipid peroxidation [1]. 
Addition of 0.1 mM BHT completely inhibited H202-in- 
duced lipid peroxidation both in the absence and in the 
presence of protoporphyrin (Table 2). Peroxide-induced 
K+-leakage, on the other hand, was not affected by the 
addition of BHT (Table 2). Furthermore, the enhancement 
of H202-induced K+-leakage by protoporphyrin was not 
affected by the addition of BHT (data not shown). These 
results indicate that also in the presence of protoporphyrin, 
there is most likely no causal relationship between H202- 
induced lipid peroxidation and K+-leakage. This is corrob- 
orated by the results obtained with diamide. Protopor- 
phyrin-induced K+-leakage was not affected by the addi- 
Table 2 
Effect of various compounds on H~O2-induced K÷-leakage and lipid peroxidation 
Addition % K+-loss MCV HzO2_induced lipid H202_induced 
in 30 min (% of control) peroxidation K+-leakage (%) 
None 2 100 1.274 50 
Protoporphyrin (0.05 raM) 20 115 0.764 (60%) 75 
Uroporphyrin (0.05 mM) 2 100 1.3 (100%) 50 
Bilirubin (0.05 mM) 2 100 0,841 (66%) 42 
BHT (0.1 raM) 2 100 0.008 (0%) 50 
Chlorpromazine (0.2 mM) 10 110 0.833 (65%) 44 
Promethazine (0.2 mM) 10 113 0.008 (0%) 40 
Diphenylamine (0.1 mM) 2 100 0,086 (7%) 98 
A 10% erythrocyte suspension was incubated with various compounds for 30 min at 30 ° C and K+-loss and MCV were determined. Initial MCV is 100% 
and initial K÷-leakage is 2%. Subsequently 20 mM H202 and 2 mM sodium azide were added and K+-leakage and lipid peroxidation were measured. 
Lipid peroxidation was determined after 120 min and numbers in parentheses give percentage of lipid peroxidation without scavengers present. K+-leakage 
was determined after 60 rain. 
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Fig. 5. The effect of diamide on K+-leakage in the presence ofprotopor- 
phyrin and H202. Erythrocytes were incubated for 30 min with 0 or 50 
/~M protoporphyrin at 30 ° C, with and without 10 mM diamide. Subse- 
quently the cells were exposed to 20 mM H202 in the presence of2 mM 
azide at 30 ° C. Open symbols: without protoporphyrin. Closed symbols: 
with protoporphyrin. (O, O) no diamide; (D, II) with 10 mM diamide. 
tion of 10 mM diamide: protoporphyrin-induced and di- 
amide-induced K+-leakage were additive (data not shown). 
The results in Fig. 5 show that HzO2-induced K+-loss was 
counteracted by pretreatment of the cells with diamide: the 
combined effect of both treatments was less than additive. 
Finally, in the presence of diamide H2Oz-induced K +- 
leakage was still enhanced by protoporphyrin (Fig. 5). 
In subsequent experiments we investigated the effect of 
various K+-channel blockers on K+-loss in the presence of 
H20 2 and protoporphyrin. HzO2-induced K+-loss was not 
affected by preincubation with 0.1 mM ouabain, 0.1 mM 
bumetanide or 0.1 mM EGTA or by substitution of NaCI 
with sucrose (results not shown). The addition of 1 mM 
furosemide inhibited H202-induced K+-leakage for 30%. 
Similar results were obtained in the presence of protopor- 
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Fig. 6. The effect of protoporphyrin o  peroxide-induced K+-leakage in a 
Tris-HCI/BaC12 buffer. Erythrocytes were incubated for 30 min with 0 
or 50 /~M protoporphyrin at 30°C in PBS or in a Tris-HC1/BaC12 
buffer. Subsequently he cells were exposed to 20 mM H202 in the 
presence of2 mM azide at 30 ° C. Open symbols: without protoporphyrin. 
Closed symbols: with protoporphyrin. (O, 0 )  PBS; ([], II) Tris- 
HCI/BaCI 2 buffer. 
phyrin: no effect was found by incubation with ouabain, 
bumetanide, EGTA or sucrose, whereas with furosemide a
30% reduction in K+-loss was found (results not shown). 
Replacement of PBS with a buffer containing 10 mM 
Tris-HC1 and 100 mM BaC12, on the other hand, markedly 
affected K+-leakage (Fig. 6). H202-induced K+-leakage 
was slightly reduced in the presence of BaCI 2. However, 
exposure of erythrocytes to H20:  and protoporphyrin i  
the BaCl2-containing buffer did not result in an enhanced 
K+-loss, as was found in PBS (Fig. 6). Lipid peroxidation 
was not affected by the change of buffers and in the 
presence of protoporphyrin peroxide-induced lipid per- 
oxidation was still inhibited (results not shown). 
4. Discussion 
We investigated the effect of protoporphyrin on perox- 
ide-induced amage, using K+-leakage and lipid peroxida- 
tion as parameters of membrane damage. The presence of 
protoporphyrin enhanced H202-induced K+-leakage con- 
siderably, whereas lipid peroxidation was inhibited (Fig. 
4). To inhibit lipid peroxidation, the porphyrin had to be 
localized in the membrane. Uroporphyrin, a porphyrin that 
remains in solution, did not affect lipid peroxidation at all. 
These results are in accordance with previous observations 
in rat liver microsomes [21]. In this case we found that 
protoporphyrin was able to inhibit lipid peroxidation in- 
duced by Fe3+-ADP/ascorbate or Fe3+-ADP/NADPH, 
whereas uroporphyrin had no effect. In the microsomal 
system complete inhibition was reached with protopor- 
phyrin concentrations between 10 and 25 /~M. In erythro- 
cytes peroxide-induced lipid peroxidation could not be 
inhibited as effectively: at 100 /~M protoporphyrin lipid 
peroxidation was inhibited for only 50%. Comparison with 
other inhibitors of lipid peroxidation showed that protopor- 
phyrin was considerably less effective than BHT or 
promethazine (Table 2). Protoporphyrin was slightly more 
effective than bilimbin, a degradation product of protopor- 
phyrin and a well-known radical scavenger [22,23]. 
Peroxide-induced K+-leakage was enhanced by the 
presence of protoporphyrin (Fig. 4). In erythrocytes, K + 
can be transported via various transport systems, which 
can be inhibited by a number of inhibitors [24]. We 
investigated whether any of these systems was involved in 
H202-induced K+-loss, either with or without protopor- 
phyrin present. Protoporphyrin-induced K+-leakage was 
not affected by the addition of 0.1 mM ouabain, inhibitor 
of the Na+/K+-ATPase, 0.1 mM bumetanide, inhibitor of 
[Na+/K+/C1 - ]  cotransport, 0.1 mM EGTA, inhibitor of 
Ca 2+ activated K+-transport or 1 mM furosemide, which 
is an inhibitor of the [K+/C1 ] cotransport. The residual 
pathway, stimulated by replacement of NaC1 with sucrose 
[24], was also not involved. Ouabain, bumetanide, sucrose 
and EGTA also failed to affect K+-leakage when cells 
were incubated with H20:  or with H20 2 and protopor- 
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phyrin. With furosemide, K+-leakage induced by H202 or 
by H202 in the presence of protoporphyrin was inhibited 
for 30%. The former is in accordance with data in the 
literature, where it was shown that K+/C1 - cotransport is 
involved in H202-induced K+-loss [25]. However, none of 
these transport systems seemed to be involved in the 
enhancement of peroxide-induced K÷-leakage by protopor- 
phyrin. This enhancement was also not affected by di- 
amide (Fig. 5). In a previous tudy we used the SH-reagent 
diamide to show that H202-induced K+-leakage was most 
likely caused by oxidation of SH-groups in the membrane 
[1]. Diamide causes an increased K+-leakage by oxidation 
of SH groups to disulfides [26,27]. As shown in Fig. 5, the 
combined effects of diamide and H202 are less than the 
effect of H202 alone, which indicates that the oxidation of 
SH groups to disulfides by diamide protects these groups 
against oxidation by H202 [1]. However, neither the K +- 
leakage induced by protoporphyrin alone nor the enhance- 
ment of H202-induced K+-leakage by protoporphyrin was 
affected by pretreatment of the cells with diamide. This 
means that these diamide and H202 sensitive SH-groups 
are not involved in the enhancement of HeO2-induced 
K+-loss by protoporphyrin. 
Another possible xplanation for the increase in K+-loss 
might be that there is a causal relationship between the 
enhancement of K+-loss and the inhibition of lipid per- 
oxidation by protoporphyrin. A reaction between peroxide- 
or lipid-derived radicals z~nd protoporphyrin could result in 
the formation of reactive intermediates, which could subse- 
quently cause an increase in K+-leakage. Such a mecha- 
nism has been proposed for diphenylamine [28]. Dipheny- 
lamine also inhibited lipid peroxidation, whereas at the 
same time K+-leakage was increased (Table 2). It was 
suggested that a diphenylamine radical, formed upon reac- 
tion of diphenylamine wS:th a lipid peroxyl radical, causes 
damage that finally leads to enhanced K+-loss. At the 
same time diphenylamine is formed back again [28]. We 
found that protoporphyrin was also not degraded, suggest- 
ing that similar reactions might take place. However, the 
experiments with BHT :and BaC12 argue against such a 
mechanism for protoporphyrin. BHT is a better radical 
scavenger than protopog~hyrin, which is illustrated by the 
fact that in erythrocytes BHT inhibited lipid peroxidation 
much more effectively than protoporphyrin (compare Fig. 
4 and Table 2). A possible reaction between lipid peroxyl 
radicals and protoporphyrin, and the subsequent increase in 
K+-leakage, would therefore be prevented by BHT. How- 
ever, the addition of BHT did not affect protoporphyrin-in- 
duced increase of K+-lcss at all, indicating that this en- 
hancement was most likely not caused by a reaction 
between peroxyl radicals and protoporphyrin. 
Secondly, we compared the effects of protoporphyrin 
on the cells in PBS and in Tris-HC1/BaCI 2 buffer. Incuba- 
tion of erythrocytes with protoporphyrin led to binding of 
protoporphyrin molecules to the cell (Fig. 1). Binding of 
protoporphyrin to the erythrocyte caused perturbations of
the membrane, as reflected by the change in cell shape, 
and the concomitant increase in MCV and K÷-loss (Table 
1). The change in cell shape was most likely caused by 
selective intercalation of negatively charged protopor- 
phyrin molecules into the outer monolayer of the mem- 
brane, resulting in expansion of the outer relative to the 
inner monolayer [29]. Compounds that produce chinocytes 
associate preferentially with the outer monolayer, probably 
as a result of their inability to cross the bilayer or because 
of charge repulsion by negatively charged inner monolayer 
lipids. BaC12 did not prevent protoporphyrin binding to the 
membrane, but prevented protoporphyrin-induced hange 
in cell shape, as well as the increase in MCV and K ÷- 
leakage. The localisation of protoporphyrin the mem- 
brane was also clearly affected by the presence of the 
barium molecules (Fig. 3). It is feasible that the positive 
barium molecules hielded the carboxylic acid groups of 
the protoporphyrin molecules from negatively charged 
lipids of the inner layer, thus changing the localisation of 
protoporphyrin and preventing the change in cell shape. 
H202-induced K--loss was slightly decreased in the Tris- 
HC1/BaC12 buffer, whereas lipid peroxidation was not 
affected. More importantly, the presence of protoporphyrin 
did no longer enhance H202-induced K+-leakage (Fig. 6). 
These results, therefore, strongly suggest hat there is a 
causal relationship between protoporphyrin-induced change 
in cell shape and the increased K---loss upon exposure of 
the cells to H202. This effect seems to be rather specific 
for protoporphyrin-induced hanges, which is corroborated 
by the following observations. Changes in cell shape can 
also be induced by positively charged molecules, like 
chlorpromazine and promethazine [30-32]. Positively 
charged compounds associate preferentially with the inner 
monolayer, inducing stomatocytosis [29]. Interestingly, 
both compounds induced an increase in MCV and K+-loss 
as a result of the change in cell shape, but they did not 
cause an increase in H202-induced K+-leakage (Table 2). 
Thus, the enhancement of H202-induced K÷-leakage is 
most likely caused by particular changes in cell shape due 
to binding of protoporphyrin, and is definitely not a gen- 
eral phenomenon. 
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